Precision Medicine in Systemic Sclerosis and Idiopathic Inflammatory Myopathies
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Personalized Therapy and Drug Delivery".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 81
Special Issue Editors
Interests: rheumatic diseases; early diagnosis; microbiota; biomarkers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to announce a Special Issue on "Precision Medicine in Systemic Sclerosis and Idiopathic Inflammatory Myopathies" in the Journal of Personalized Medicine. This Issue will focus on the emerging role of precision medicine in the diagnosis, treatment, and management of systemic sclerosis (SSc) and idiopathic inflammatory myopathies (IIMs).
Systemic sclerosis and idiopathic inflammatory myopathies are chronic autoimmune diseases characterized by a complex pathophysiology and variable clinical outcomes. As the burden of these diseases grows, personalized approaches to treatment and diagnosis are becoming increasingly important.
Over the past decade, significant strides have been made in understanding the molecular mechanisms underlying SSc and IIMs, but challenges remain in translating these findings into clinical practice. Precision medicine, through the use of biomarkers, genetic profiling, and tailored therapies, holds promise for improving patient outcomes.
This Special Issue aims to highlight recent advances in precision medicine as applied to SSc and IIMs. We seek to explore novel diagnostic tools, personalized treatment strategies, and the role of genetic, environmental, and immune factors in disease progression.
Cutting-edge research:
We are looking to feature cutting-edge research that integrates novel biomarkers, innovative therapeutic approaches, and strategies for personalized care. The Special Issue will emphasize research that brings precision medicine to the forefront of clinical practice for these autoimmune diseases.
What kind of papers we are soliciting:
We invite submissions of original research articles, clinical studies, and comprehensive reviews addressing any of the following themes:
- Precision medicine overview;
- Internal organ involvement (lung, heart, gastrointestinal, muscle) and precision medicine in SSc and IIMs;
- Early diagnosis and prognostic biomarkers in SSc and IIMs;
- Precision treatment strategies and personalized therapies;
- Advances in targeted therapies and immunomodulatory approaches;
- Genetic and epigenetic factors influencing disease progression;
- Clinical applications of precision medicine in the management of SSc and IIMs.
We look forward to receiving your contributions and to advancing the field of precision medicine for these complex diseases.
Dr. Silvia Bellando Randone
Dr. Lorenzo Cavagna
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- systemic sclerosis
- idiopathic inflammatory myopathies
- precision medicine
- autoimmune diseases
- biomarkers
- genetic
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
